Casodex® 50 mg Film-coated Tablets

DRUG2 trials

Sponsors

Cancer Trials Ireland

Conditions

Localised prostate cancer at high risk of recurrenceMetastatic Prostate Cancer

Phase 3

Randomised phase 3 trial of enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised, prostate cancer: ENZARAD

CompletedCTIS2024-514808-13-00

Cancer Trials IrelandLocalised prostate cancer at high risk of recurrence

Start: 2015-03-06End: 2025-10-03Target: 79Updated: 2026-01-23

Randomised phase 3 trial of enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: ENZAMET

Active, not recruitingCTIS2024-516137-13-00

Cancer Trials IrelandMetastatic Prostate Cancer

Start: 2014-12-18Target: 82Updated: 2025-08-05